Loading…
logo
Mozifor 24 mg Injection
Mozifor 24 mg Injection
Prescription Required
Prescription Required

Mozifor 24 mg Injection | 1.2 ml 1 Vial

23395.00
You Save ₹ 19505.00
(Inclusive of all taxes)
discount
45% OFF
wishlist
Hetero Healthcare Ltd
Plerixafor 24 mg
wishlist

Introduction of Mozifor Injection

Mozifor 24 mg Injection is an immunostimulant used in cancer patients, It mobilizes hematopoietic stem cells into blood stream. The chemical formula of this molecule is C28H54N8. It is also known as a Hematopoietic stem cell mobilized. Mozifor 24 mg Injection causes blood cells to move from the bone marrow towards blood so they can be extracted for transplant


Uses of Mozifor Injection

  • Non Hodgkin's lymphoma
  • Multiple Myeloma


Benefits of Mozifor Injection

Mozifor 24 mg Injection is used as a peripheral blood stem cell mobilization, which is a very useful source of hematopoietic stem cells for transplantation.


Side Effects of Mozifor Injection

  • Burning
  • Crawling
  • Itching
  • Numbness
  • Vomiting
  • Headache


Most Common Side Effects of Mozifor Injection

  • Constipation
  • Nausea
  • Dry mouth
  • Numbness
  • Stomach upset
  • Bloating
  • Lethargic
  • Muscle pain
  • Profuse perspiration
  • Rashes
  • Irritation


Common Side Effects of Mozifor Injection

  • Bleeding
  • Unusual weakness
  • Severe epigastric pain
  • Joint pain
  • Dizziness


How to Use Mozifor Injection?

Mozifor 24 mg Injection is available as an injectable form that must be administered under the skin ( subcutaneously) as directed by your doctor under medical supervision only. Mozifor 24 mg Injection is usually given 11 hours prior to blood filtering procedure. Dosage and frequency will be decided by your doctor as per your medical condition and weight and certain other factors.


How Mozifor Injection Works?

Mozifor 24 mg Injection is an inhibitor of the CXCR4 chemokine receptor and blocks the binding of its cognate ligand, SDF- 1 alfa. Once in the marrow, stem cell CXCR 4 can act to help anchor stem cells to the marrow matrix either directly via SDF -1 alfa or through the induction of other adhesion molecules. Treatment with plerixafor results in leukocytosis and elevations in circulating hematopoietic progenitor cells.

INDIA’S LARGEST SPECIALITY MEDICINES PLATFORM
Genuine Medicines

Genuine Medicines

Fast Delivery

Fast Delivery

Secure Payment

Secure Payment

Best prices & offers

Best prices & offers